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eciphering the chemical codes used by cells provides valuable insights, many of which will help toward ameliorating diseases. In contrast to impressive progress decoding genomics and proteomics, efforts to crack the code for the third major class of biopolymers, carbohydrates, continue to prove frustrating. Glycomics, the systematic study of carbohydrate polymers and oligosaccharides, lags a distant third compared to genomics and proteomicsdespite the ubiquitous presence of carbohydrates at cell surfaces, where cells engage in important molecular-based signaling.
Glycolipids and glycoproteins play important but poorly understood roles in regulating processes in mammalian cells and maintaining human health. At the molecular level, pathogens exploit carbohydrate structures that decorate mammalian cell surfaces, often using those structures as a means to infect such cells. By focusing on the glycolipids and glycoproteins that microbial pathogens target, we can begin to decipher the complex language of cell surface carbohydrates. Glycomics is providing us a more comprehensive approach to understanding how microbes interact with such carbohydrate receptors and could lead to the development of novel therapeutics and diagnostics.
Nucleic Acids, Proteins, and Sugars Embody Distinctive Coding
DNA, RNA, and proteins embody linear codes-arrays of four nucleotides in the case of nucleic acids, and 20 amino acids for proteins. In general, mammalian carbohydrates are composed of nine distinct types of monosaccharides along with some variations (Fig. 1) . Moreover, the ways in which carbohydrates are linked further complicates efforts to describe sugar-containing polymers-let alone try to understand the biological effects of those different linkages. For example, any pair of six-carbon monosaccharides can be linked in 11 different ways (Fig. 2) . Assuming that nine distinct types of monosaccharides are available, there are 9 ϫ 9 ϫ 11, or 891, 2-letter words for these sugars. In comparison, two amino acids can be joined in only one way, creating only 20 ϫ 20, or 400, 2-letter words.
With each additional unit, the number of potential combinations of sugars rapidly outpaces those for comparable peptides and proteins. For example, although six amino
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acids can be combined to form 6.4 ϫ 10 7 distinct hexapeptides, six monosaccharides theoretically yield 1.44 ϫ 10 15 distinct hexasaccharides. Positional isomerism, conformational changes, and hydrogen bonding can further alter oligosaccharide structures, and each variant has distinctive physicochemical and cellsignaling properties.
While nucleic acids and proteins can be unambiguously represented through the use of oneletter code words, there is no comparably simple way to represent combinations of complex sugars. To deal with the greater complexity of carbohydrates, Ajit Varki of the University of California, San Diego, devised a way to represent glycan structures (see www.functionalglycomics .org/glycomics/molecule/jsp/carbohydrate/carb MoleculeHome.jsp). Each sugar type with the same mass uses the same symbol. Thus, for example, hexoses are circles; glucose is a blue circle, galactose a yellow circle, and mannose a green circle. In nature, some carbohydratecontaining materials serve disparate functions and some are remarkably multifunctional. For example, the carbohydrate-based molecule, hyaluronan, plays important roles in ovulation and fertilization, morphogenesis, tissue remodeling, atherosclerosis, restenosis, and other cellular processes. Some streptococcal strains also contain hyaluronan in their capsular material; its nonantigenic quality enables these microbes to avoid the host immune system.
Glycoproteins and Glycolipids
In many instances, specific oligosaccharides are attached to particular proteins, making them glycoproteins and adding further overall complexity. Carbohydrates typically are linked to proteins in one of two ways. If a protein is O-glycosylated, the hydroxyl of a serine, threonine, or hydroxyproline amino acid residue becomes linked to the anomeric carbon (carbon number 1 of the carbohydrate residues in Fig. 1 ) of N-acetylgalactosamine. If N-glycosylated, the sugar, typically N-acetylglucosamine, becomes directly linked to the amide nitrogen of an asparagine residue.
These two types of glycosylation differ in several other ways. O-linked sugars typically are added one at a time to a protein, and generally contain only a few residues, typically no more than four. When a protein is N-glycosylated, however, oligosaccharide structures already containing as many as 14 residues are assembled separately before being linked to aspargine residues on the recipient protein. Once attached, the sugar unit can be further modified by enzymes that either add or delete sugar residues. There is more diversity in O-glycosylation than N-glycosylation because of the different biochemical pathways that lead to these products.
The current consensus is that sugars promote proper folding of proteins by stabilizing particular conformations and, in some cases, protecting the protein portion of the glycoprotein against degradative enzymes. The semiflexible nature of the sugars in a glycoprotein allows for many more conformations than would their 
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The nine common sugar "letters" of glycomics. The color symbol for each sugar is pictured next to the sugar name.
Weiss Studies both "Northern," or Respiratory, and "Southern," or Diarrheal Pathogens "I find it hard to accept a future where death can lurk in your spinach," says microbiologist Alison Ann Weiss of the University of Cincinnati, who describes herself as an "avid gardener." Doubtless her hands-on interest in food safety was a factor in her adding Shiga toxin to the set of bacterial toxins that she studies.
One of Weiss' current projects focuses on in vivo signals that promote Shiga toxin expression and its release from Escherichia coli O157:H7, as well as "why one antigenic form, Stx2, is 100 to 1,000 times more potent than Stx1," she says. "What is especially interesting is that Stx1 is more toxic to cells in culture than Stx2, just the opposite of what is seen in intact animals." Weiss, 54, was born in Milwaukee, the second of six children. Although mainly a "city kid," early in life she learned firsthand about farming from her grandfather, who owned a dairy farm. "Sometimes we would graze a steer on his land, and once we butchered it in our basement," she recalls. Her grandfather's farm was at the top of a hill, and her family had a garden at the bottom that was "fertilized by the manure that gently decomposed on the way down.
"Times have changed," she points out. "Unlike people, cattle are not susceptible to Shiga toxin and can carry E. coli O157:H7 asymptomatically. Crops exposed to fecal runoff are a major source for human infection."
Weiss grew up during the Vietnam War era "when young people challenged authority and conventional wisdom at every level." So it was in her household. "My father and I loved each other, but we also loved to argue, a trait he also shared with his father," she says. "We would have at it over 'conventional wisdom' every night at the dinner table. Later, I learned our arguments gave my siblings indigestion."
In those days, she continues, "Women were not encouraged to pursue careers in science. When I told my mother I didn't want to go to college, she was pragmatic and told me to take typing courses, which she knew would provide exactly the motivation I needed." Weiss received her A.B. in 1975 from Washington University in St. Louis and her M.S. in 1981 from the University of Washington in Seattle. She received her Ph.D. in 1983 from Stanford University, where her thesis advisor was Stanley Falkow. "Stanley has the extraordinary ability to inspire everyone to perform beyond expectations," she says.
Falkow's wife, Stanford University microbiologist Lucy Tompkins, "once told me she attributed the massive entry of women into science to the Vietnam War," Weiss says. "Drafteligible men could get a deferment for undergraduate education, but not a deferment to pursue graduate studies. Suddenly, women comprised the bulk of the pool of applicants to postgraduate programs, likely due to challenges to the idea that women shouldn't pursue higher education-and a reduction in the pool of male applicants."
Weiss wryly refers to bacterial pathogens that cause diarrhea as "'Southern hemisphere' agents . . . that hit you 'below the belt,'" and to pathogens that cause respiratory diseases as "'Northern hemisphere,' agents." In Falkow's lab, "mostly everyone was working with a below-the-belt agent," she says. "Whether it was psychosomatic or not, everyone seemed to get a bit 'loose' immediately after they started working in Stanley's lab.
"I bucked the trend and worked with a Northern hemisphere agent, the respiratory pathogen Bordetella pertussis," she says. This pathogen, which causes pertussis, or whooping cough, makes a toxin that is "essential for virulence." For example, it "disrupts cellular communication mediated by GTP-binding proteins, and has a profound influence on the ability to mount an effective immune response," she points out. "Currently we are looking at how pertussis toxin alters T cells. While I haven't stopped working with B. pertussis, I feel like my studies with E. coli O157:H7 are returning me to my 'Southern hemisphere' roots."
Weiss and her husband, an immunologist, have two teenage children, a 17-year-old son and a 14-year-old daughter. "My son has been doing graphic arts for me; he generated schematics for this piece, and he made the logo for the Midwest Microbial Pathogenesis Conference," she says. purely protein amino-acid counterparts. One of the biggest challenges in glycobiology is the lack of analytic means for delineating the effects of individual molecular components on downstream signaling mechanisms. Glycolipids bring in another set of complexities. One or more of the hydrophilic sugars ( Fig.  1) can be directly attached to hydrophobic lipids embedded in the outer leaflet of lipid bilayers in mammalian membranes. Glycolipids can form clusters within such membranes, called lipid rafts. Such rafts consist of glycosphingolipid microdomains that are enriched in cholesterol. These domains facilitate protein-protein and lipid-protein interactions at cell surfaces and play a critical role in communications between cells. An important class of glycolipids includes the gangliosides, which are composed of a glycosphingolipid (oligosaccharide and ceramide) containing one or more sialic acids residues on the sugar chain. Gangliosides are abundantly present on neurons, making them a target for toxins.
Marlene Cimons

Some Pathogens Key in on Complex Carbohydrates on Host Cells
Not only eukaryotes, but also bacteria make both O-linked and N-linked glycoproteins. For example, Campylobacter jejuni and Campylobacter coli coat their flagella with acetamidinosubstituted analogs of N-acetyl neuraminic acid, and this coating is required for cell motility. Even though bacterial pathogens apparently do not use sugars to communicate among themselves, microbial cells and their toxins impinge on the carbohydrates that decorate mammalian cell surfaces-for example, gaining entry into mammalian cells by binding to different sugar-containing receptors. Researchers are beginning to identify the broad specificities of some pathogen-carbohydrate interactions and toxin-carbohydrate interactions (see table) .
Prominent examples include influenza virus, and bacterial toxins such as botulinum toxin, Shiga toxin, and pertussis toxin. Each example illustrates different facets of the biology of sugars on mammalian host cells and the roles that they can play in infectious diseases.
Carbohydrates Affect Tissue Tropism, Virulence, Transmissibility of Influenza Virus
Understanding the crosstalk between host carbohydrates and pathogens such as influenza virus could prove especially valuable from a public health standpoint. With highly pathogenic strains of avian influenza now circulating, one major concern is whether strains will emerge that can transmit freely and efficiently among humans. This concern is further amplified because some strains of avian influenza are resistant to available antiviral drugs.
Influenza viruses, including the highly pathogenic avian H5N1 species, carry two glycoproteins on their surfaces-hemagglutinin (HA) and neuraminidase (NA) that bind to N-acetyl neuraminic acid (sialic acid) residues on host cells. These interactions with sialic acid are es- sential for influenza viruses to enter mammalian cells. Indeed, sialic aciddeficient cells are impervious to this virus. Each influenza viral particle possesses approximately 500 copies of HA trimers and 100 copies of NA tetramers on its surface. The HA trimers mediate cell recognition and entry. Viral host range strongly depends on the ability of HA to recognize specific structural features of sialic acid derivatives and also the density and presentation of these sugar residues on host cells (see table) . For example, influenza C virus infects animal cells that display 9-O-acetyl sialic acids on their glycoproteins and glycolipids, while avian influenza strains preferentially target sialic acids linked to the 3 position, and influenza strains that infect humans preferentially target sialic acids linked to the 6 positions of galactose or lactose.
This preferential recognition of specific forms of sialic acid has significant implications for viral transmission and pathogenesis. For instance, the upper respiratory tract of humans is rich in ␣-2,6 sialic acid-linked glycans (Fig. 3 , denoted in blue), whereas cells in the lower respiratory tract are rich in terminal ␣-2,3 linkages (Fig. 3, in green) . When influenza infects the upper respiratory tract, high concentrations of viral particles in respiratory secretions enhance human to human transmission via coughing and sneezing. In contrast, viral replication in the lower respiratory tract hinders transmission. This greater efficiency of transmission helps to explain why influenza strains that preferentially bind ␣-2,6 sialic acids of the upper respiratory tract are predominant among humans.
In contrast, the preference of avian influenza for ␣-2,3 sialic acids suits the H5N1 virus for infecting the intestinal tract of birds, but makes them not so effective with humans. However, when H5N1 viruses reach the lower respiratory tract, they tend to cause severe, life-threatening infections, particularly because gas exchange becomes compromised.
This ␣-2,3 sialic acid binding preference helps to explain what happens when humans become infected with avian influenza. Thus, infection rates are low, usually requiring close contact with birds, and human to human transmission is rare. However, mortality is extremely high. The deadly 1918 influenza pandemic is believed to have been due to an avian virus that mutated from an ␣-2,3 sialic acid binding preference to ␣-2,6, while retaining its high pathogenic potential, making this virus both highly contagious and highly virulent. Whether the currently circulating strains of avian influenza will mutate to recognize ␣-2,3 and ␣-2,6 linkages to become highly transmissible remains an open concern.
Understanding these molecular details involving sialic acids is crucial for the development of antiviral drugs. Viral neuraminidase cleaves sialic acid residues from infected cells, releasing viral progeny that infect new cells. Influenza drugs, such as Relenza and Tamiflu, are analogs that bind and inactivate neuraminidase. However, some avian influenza strains now are resistant to Tamiflu, making it important to pursue alternative means for inhibiting these 
Bacterial Toxins Such as Botulinum Toxin Bind Carbohydrate Receptors
Although many bacterial toxins enter cells via protein receptors, other toxins, including several on the biothreat list such as the botulinum neurotoxins and Shiga toxin, depend partly or fully on carbohydrate receptors (see table) . Even though protein receptors confer exquisite selectivity, cells generally express few molecules of a particular protein, whereas carbohydrate residues typically are abundant. Moreover, the same glycosylation pattern may decorate many different proteins on a single cell type, while also decorating each protein at several sites. Thus, the extremely high potency of some biothreat toxins may reflect their binding to high-density carbohydrate receptors.
The family of seven botulinum neurotoxins (BoNT) produced by Clostridium botulinum, a gram-positive, spore-forming bacterium, are among the most toxic substances found in nature. The A subunit of BoNT is a protease that cleaves components of the secretory machinery in mammalian nerve cells. Cleavage then prevents acetylcholine-containing vesicles from fusing with the terminal membranes of motor neurons, leading to flaccid muscle paralysis and, ultimately, death due to respiratory failure. One gram of aerosolized BoNT serotype A is enough to cause more than 1 million deaths. A single lethal dose of about 10 10 molecules, or 10 ng, happens to be the same as the number of neurons in a human.
BoNT gains entry into cells via two distinct types of receptors-ganglioside carbohydrate receptors, such as GT1b or GD1a, and a protein receptor, synaptotagamin. The ganglioside coreceptors are highly expressed at nerve terminals, and aid in defining such cells as targets for this toxin. The gangliosides provide a high-density, low-affinity receptor-enabling high concentrates of BoNT to build on nerve cell surfaces, increasing the probability that the toxins will bind synaptotagamin, its low-density, highaffinity receptor.
Synaptotagamin, which is part of the neurotransmitter secretory machinery, further defines the cell as a BoNT target. Synaptotagamin is incorporated into secretory vesicles and is expressed transiently on cell surfaces immediately after secretory vesicles fuse at presynaptic nerve terminals and before endocytosis recycles membrane components. Molecules of BoNT bind to gangliosides at the cell surface, then bind to molecules of synaptotagamin once they become surface exposed. As endocytosis internalizes synaptotagamin, any BoNT that is bound to those molecules also is internalized.
The seven serotypes (A-G) of botulinum neurotoxin differ in toxicity. Most (52%) human botulism cases result from BoNT/B, followed by BoNT/A at 34%, and BoNT/E at 12%. The other serotypes do not appear to be toxic for humans. It appears that affinity for the ganglioside receptor dictates susceptibility, and minor structural differences can determine the difference between life and death following exposure to these toxins. For example, GT1b and GD1b, gangliosides that differentially bind BoNT/B, differ from one another by a single sialic acid moiety. The differences are even more subtle between GD1a, which binds BoNT/B with lower Gal (␣1,4) Gal(␤1,4)Glc-ceramide (Gb3) and analogues Pertussis toxin Sialic acid, Gal(␤1,4)Glc-ceramide, gangliosides Cholera toxin and LT-I Ganglioside GM1 E. coli enterotoxin, LT-IIa Gangliosides GD1b, GD1a, GM1
efficiency, and GD1b. GD1b and GD1a differ only in position of one sialic acid present in both gangliosides. More detailed information about the effects of structure on activity might help medicinal chemists develop better inhibitors and diagnostics for this deadly toxin.
Multivalency of Shiga Toxin Ensures Affinity for Receptor
Shiga toxin is a major virulence factor of several types of gram-negative bacteria, including Escherichia coli O157: H7. Shiga toxin belongs to the AB 5 family of toxins (Fig. 4) . The A subunit is an N-glycosidase, which cleaves single adenine residues from 28S ribosomal RNA molecules, rendering the ribosome incapable of synthesizing proteins. Curiously, this same activity is associated with the select agent from castor bean plants, ricin, which preferentially binds to both galactose and Nacetylgalactose. However, the B, or binding subunit of Shiga toxin, binds to terminal sugars on globotriaosylceramide (Gb3), delivering the A catalytic subunit to its cytoplasmic target. The B subunit of Shiga toxin consists of five identical polypeptides, each with multiple binding sites for Gb3 (Fig. 4A) . While the binding affinity for individual molecules of Gb3 is very low, the affinity of the toxin for its receptor increases more than 1,000-fold when that receptor is embedded in a membrane in the form of a lipid raft on mammalian cell surfaces. The sugar residues in such membranes are tightly clustered and thus can simultaneously engage multiple binding sites on the toxin. The low-affinity interactions are synergistic, amounting to binding forces that rival antibody affinities in strength. Furthermore, variations in the structure of the glycolipid can lead to selectivity between serotypes, and small structural changes in the host receptor can lead to high specificity between closely related Shiga toxins.
In targeting glycolipids in lipid rafts, Shiga toxin gains another advantage. Because lipid rafts play a critical role in cell-signaling processes and Gb3 associates with lipid rafts, bound toxin molecules do not depend merely on receptor turnover to carry them into cells. This targeting enables B subunits to activate Src family kinases within minutes of binding to cells, promoting rapid toxin entry. Furthermore, this signaling may determine the fate of the toxin, which is not toxic to all cells. For example, although Shiga toxin enters the cytoplasm and damages ribosomes in susceptible cells, toxinresistant bovine cells shuttle Shiga toxin to lysosomes to be degraded, allowing cattle to carry E. coli O157:H7 without developing symptoms.
Pertussis Toxin: Lectin Activity and a Second Layer of Toxicity
Pertussis toxin is the major virulence factor of Bordetella pertussis, which infects humans and causes whooping cough. Whooping cough has the dubious distinction of being the only vaccine-preventable disease that is increasing in incidence in the United States. Its toxin is the most complex bacterial toxin described to date.
Like Shiga toxin, pertussis toxin is an AB 5 toxin, with an enzymatically active A subunit and a 5-member B (binding) subunit (Fig. 4) . The A subunit catalyzes transfers of the ADPribosyl group of nicotine adenine dinucleotide (NAD) to regulatory GTP-binding proteins of mammalian cells, ultimately disrupting G-protein-mediated intracellular signaling. Unlike Shiga toxin, the B subunits of pertussis toxin are not identical. Instead the pertussis toxin B-pentamer (Ptx-B) is composed of four different subunits termed S2, S3, S4, and S5 in a 1:1:2:1 ratio (Fig. 4C-D) . The B subunit not only transports A subunits into the cytoplasm of target cells, but also possesses a toxicity of its own. Thus, Ptx-B binds to and promotes signaling through diverse receptors on different classes of mammalian cells, including glycoprotein 1B expressed by platelets, Mac-1 (CD11b/CD18) expressed on monoblasts, CD14 expressed by macrophages, TLR-4 expressed by dendritic cells, and the T-cell receptor expressed by T cells. This ability to affect so many different receptors on such a diverse array of cells suggests that these cells and receptors share some property. In fact, all these receptors are glycosylated, and all of them are sensitive to activation by clustering. Specifically, Ptx-B activates these receptors by clustering them, and Ptx-B clusters them by binding to their sugars.
This activity of Ptx-B is analogous to that of plant lectins, which contain two or more carbohydrate binding domains and activate cells by clustering receptors expressing appropriate binding sugars. For instance, concanavalin A (ConA) and Phaseolus vulgaris lectin, PHA, activate T-cells of the immune system. While lectins typically possess identical binding sites, PTX-B has five binding sites that recognize different sugars, including three sialic acid binding sites, a lactosylceramide-binding site, and a ganglioside-binding site. Ptx-B targets so many different cell types and receptors because it binds such diverse sugars.
While Ptx-B is a mammalian cell toxin, it also has limited antiviral activity. It can prevent replication of HIV in peripheral blood leukocytes in vitro, in activated primary T-cells, monocytederived macrophages, and in ex vivo cultures of human lymphoid tissues. In vivo, Ptx-B has activity against simian immunodeficiency virus (SIV) in chronically infected macaques, and against HIV in SCID mice reconstituted with human peripheral blood leukocytes. Thus, this lectin-like activity of pertussis toxin could lead to development of novel therapies for treating HIV.
Concluding Remarks
Several novel methods have been developed to probe the interactions of cell-surface carbohydrates with their receptors. Metabolic engineering allows for the creation and study of cells deficient in glycosylation or directed to display unnatural sugar patterns on the cell surface. Glycomicroarrays have been generated, but are limited by the lack of pure preparations of complex sugars. Recent advances in synthetic tools such as enzymatic, programmable one-pot and solid-phase synthesis have alleviated the bottleneck for some compounds. However, there are still challenges to be met. Finally, the study of glycolipids and glycoproteins targeted by microbial pathogens provides yet another research tool to investigate the basic biology of cellsurface carbohydrates.
The Consortium for Functional Glycomics (CFG-http://www.functionalglycomics.org/ static/index.shtml) is a large research initiative composed of more than 300 Participating Investigators and seven scientific core laboratories. Funded by the National Institute of General Medical Sciences in 2001 to elucidate the roles of carbohydrate-protein interactions in cell communication at the cell surface, the CFG has made enormous progress towards its goals. The scientific cores produce a variety of resources and services for investigators performing experiments that address the goals of the CFG. Data produced by the scientific cores are accessible from their website. Specialty databases for glycan-binding proteins, glycan structures, and glycosyltransferases are also available.
